References
- Godfroid J, Cloeckaert A, Liautard JP, et al. From the discovery of the Malta fever’s agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis. Vet Res. 2005;36(3):313–326.
- Zinsstag J, Schelling E, Roth F, et al. Human benefits of animal interventions for zoonosis control. Emerg Infect Dis. 2007;13(4):527–531.
- Garin-Bastuji B, Blasco JM, Grayon M, et al. Brucella melitensis infection in sheep: present and future. Vet Res. 1998;29:255–274.
- Stevens MG, Olsen SC, Cheville NF. Comparative analysis of immune responses in cattle vaccinated with Brucella abortus strain 19 or strain RB51. Vet Immunol Immunopathol. 1995a;44(3–4):223–235.
- Lord VR, Schurig GG, Cherwonogrodzky JW, et al. Field study of vaccination of cattle with Brucella abortus strains RB51 and 19 under high and low disease prevalence. Am J Vet Res. 1998;59(8):1016–1020.
- Beckett FW, MacDiarmid SC. The effect of reduced-dose Brucella abortus strain 19 vaccination in accredited dairy herds. Br Vet J. 1985;141(5):507–514.
- Spink WW, Hall JW 3rd, Finstad J, et al. Immunization with viable Brucella organisms. Results of a safety test in humans. Bull World Health Organ. 1962;26:409–419.
- Ashford DA, Di Pietra J, Lingappa J, et al. Adverse events in humans associated with accidental exposure to the livestock brucellosis vaccine RB51. Vaccine. 2004;22(25–26):3435–3439.
- Adone R, Ciuchini F, Marianelli C, et al. Protective properties of rifampin-resistant rough mutants of Brucella melitensis. Infect Immun. 2005;73(7):4198–4204.
- Eker A, Uzunca İ, Tansel Ö, et al. A patient with brucellar cervical spondylodiscitis complicated by epidural abscess. J Clin Neurosci. 2011;18(3):428–430.
- Dorneles EM, Sriranganathan N, Lage AP. Recent advances in Brucella abortus vaccines. Vet Res. 2015;46:76.
- Edmonds M, Booth N, Hagius S, et al. Attenuation and immunogenicity of a Brucella abortus htrA cycL double mutant in cattle. Vet Microbiol. 2000;76(1):81–90.
- Kittel C, Sereinig S, Ferko B, et al. Rescue of influenza virus expressing GFP from the NS1 reading frame. Virology. 2004;324:67–73.
- Brown IH, Crawshaw TR, Harris PA, et al. Detection of antibodies to influenza A virus in cattle in association with respiratory disease and reduced milk yield. Vet Rec. 1998;143:637–638.
- Gunning RF, Brown IH, Crawshaw TR. Evidence of influenza A virus infection in dairy cows with sporadic milk drop syndrome. Vet Rec. 1999;145:556–557.
- Graham DA, Calvert V, McLaren E. Retrospective analysis of serum and nasal mucus from cattle in Northern Ireland for evidence of infection with influenza A virus. Vet Rec. 2002;150:201–204.
- Tabynov K, Sansyzbay A, Kydyrbayev Z, et al. Influenza viral vectors expressing the Brucella OMP16 or L7/L12 proteins as vaccines against B. abortus infection. Virol J. 2014;11:69.
- Tabynov K, Kydyrbayev Z, Ryskeldinova S, et al. Novel influenza virus vectors expressing Brucella L7/L12 or Omp16 proteins in cattle induced a strong T-cell immune response, as well as high protectiveness against B. abortus infection. Vaccine. 2014;32:2034–2041.
- Tabynov K, Ryskeldinova S, Kydyrbayev Z, et al. Safety of the novel influenza viral vector Brucella abortus vaccine in pregnant heifers. Cienc Rural. 2016;46(1):114–118.
- Tabynov K, Yespembetov B, Sansyzbay A. Novel vector vaccine against Brucella abortus based on influenza A viruses expressing Brucella L7/L12 or Omp16 proteins: evaluation of protection in pregnant heifers. Vaccine. 2014;32:5889–5892.
- Tabynov K, Yespembetov B, Ryskeldinova S, et al. Prime-booster vaccination of cattle with an influenza viral vector Brucella abortus vaccine induces a long-term protective immune response against Brucella abortus infection. Vaccine. 2016;34:438–444.
- Tabynov K, Ryskeldinova S, Sansyzbay A. An influenza viral vector Brucella abortus vaccine induces good cross-protection against Brucella melitensis infection in pregnant heifers. Vaccine. 2015;33(31):3619–3623.
- Schurig G, Boyle S, Sriranganathan N. Brucella abortus vaccine strain RB51: a brief review. Arch Med Vet. 1995;27:19–22.
- Ko J, Splitter GA. Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans. Clin Microbiol Rev. 2003;16:65–78.
- Romanova J, Krenn BM, Wolschek M, et al. Preclinical evaluation of a replication-deficient intranasal DeltaNS1 H5N1 influenza vaccine. PLoS One. 2009;4(6):5984.
- Ferko B, Stasakova J, Romanova J, et al. Immunogenicity and protection efficacy of replication-deficient influenza A viruses with altered NS1 genes. J Virol. 2004;78:13037–13045.